Amputation, one of worse prognostic variables

Original title: Lower Extremity Amputation: Factors Associated With Mortality or Contralateral Amputation Reference: Samir K. Shah, et; al. Vascular and Endovascular Surgery 2013:47 (8):608-613.

Peripheral vascular disease is associated with trophic injuries with tissue lose, often leading to amputation, of which about 50 % were major amputations. 454 amputations in 391 patients were analyzed, 63 were contralateral. Most of the patients have received prior treatment before amputation, which generally was angioplasty procedure.

The amputation rate was 70% transtibial and 30% transfemoral. Mortality at 30 days after amputation was 9.2 %, and after 1, 2 and 5 years revealed 30%, 40% and 56 % respectively, with an average survival of 25.4 months. The variables associated with mortality were age, dialysis, high cardiac risk and transfemoral or transtibial amputation. The need of dialysis and high cardiac risk were associated with contralateral amputation. The only variable that produced protection against death was the contralateral limb intervention. Survival free of contralateral amputation – at 1, 2 and 5 years was 60 %, 49 % and 33 % respectively. The following factors with high risk were associated with contralateral amputation:  Age and moderate or high cardiac risk, having the intervention in that limb a protective effect.

Conclusion

Patients with advanced peripheral vascular disease requiring amputation of one lower limb have a decrease in survival and a high rate of amputation of the contralateral limb. Age and dialysis are factors that predispose to amputation. These data favor the strategies to improve limb preservation. 

Comment

Amputation is associated with poor short-term outcome and increases the risk of repeated in the contralateral limb. It is necessary to optimize medical treatment and education of patients and their relatives in order to prevent or avoid trophic lesions. It is very important before performing angiographic studies or try limb revascularization in the best possible way, once or several times before making the final decision. 

Courtesy of Carlos Fava MD
Interventional Cardiologist
Favaloro Foundation
Argentina

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....